The Challenge: Ineffective Medical Representative Engagement with Oncologists
Pharmaceutical companies struggle to effectively engage oncologists, hindering advancements in patient care and treatment innovation in oncology.
The Loss: Impact on Patient Care and Treatment Innovation
Suboptimal MR activities lead to delayed adoption of new cancer treatments and techniques, resulting in prolonged patient suffering, higher treatment costs, and missed opportunities for early intervention.
Data underscores a direct correlation between effective engagement strategies and improved patient outcomes in oncology, emphasizing the critical need for targeted approaches to enhance physician education and patient care.
The Solution: Innovating MR Engagement for Oncologists
Pixika AI introduces a cutting-edge mobile app designed to enhance MR engagement with oncologists. Our platform utilizes personalized digital strategies, including web-to-web and web-to-print solutions, to deliver targeted promotional inputs and educational resources.
We empower pharmaceutical companies to optimize their interactions with oncologists, accelerating the adoption of new treatments and improving patient outcomes.
Establishing Credibility
As pharmaceutical business growth experts, Pixika AI collaborates with over 70 top global healthcare companies, impacting approximately 500,000 doctors annually through digital and print initiatives. Our solutions have significantly contributed to achieving cumulative revenues of 9700 crores and maintaining an average rating of 4.1 stars from 75% repeat customers.